Referred to the House Committee on Energy and Commerce.
This resolution is a non-binding statement by the House recognizing July 28, 2026, as World Hepatitis Day and expressing support for prevention, testing, vaccination, and treatment efforts. It does not create new law, authorize spending, or change existing legal obligations. It asks the Centers for Disease Control and Prevention to partner with state and local health departments to increase hepatitis B vaccination and hepatitis C treatment. In practice it communicates the House's priorities and encourages public health action.
This is a simple House resolution that only the House can adopt; it does not go to the President and is not legally binding. It expresses the chamber's views and calls for action but does not create enforceable law or funding.
This House resolution designates July 28, 2026, as World Hepatitis Day and summarizes domestic and global hepatitis B and C burdens.
It affirms support for broad access to hepatitis B vaccination, hepatitis C treatment, increased screening, public education, and urges CDC partnerships with state and local health departments to raise adult vaccination and treatment rates.
The resolution notes disparities, the role of people who inject drugs, and mentions sterile injection equipment as a prevention intervention.
As a simple House resolution it cannot become law; passage is symbolic, not statutory change.
Relative to its intended legislative type, this bill functions as a commemorative House resolution that clearly states the public-health problem and expresses congressional recognition and support. It includes nonbinding calls for administrative action but does not create legal obligations, allocate resources, or establish enforcement or reporting mechanisms.
Harm reduction endorsement versus objections to syringe access programs
These are examples from the analysis, not a ranked list of the most-affected groups.
Harm reduction endorsement versus objections to syringe access programs
Likely strongly supportive: applauds attention to preventable, underdiagnosed infectious diseases and emphasis on harm reduction.
Views CDC-state partnerships and calls for universal screening and vaccination as necessary public health steps.
Generally favorable but pragmatic: supports awareness, screening, and vaccination while wanting clear implementation, measurable goals, and fiscal clarity.
Sees CDC collaboration as sensible if paired with accountability and state coordination.
Mixed to somewhat skeptical: supports awareness, vaccination, and treatment expansion, but concerned about federal overreach, lack of funding, and endorsement of syringe exchange programs.
Prefers state control and limited federal directives.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a simple House resolution it cannot become law; passage is symbolic, not statutory change.
The bill has not accumulated any surfaced votes yet.
Harm reduction endorsement versus objections to syringe access programs
As a simple House resolution it cannot become law; passage is symbolic, not statutory change.
Relative to its intended legislative type, this bill functions as a commemorative House resolution that clearly states the public-health problem and expresses congressional recognition and support. It includes nonbindin…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.